It is generally accepted that Notum is a glypican-specific phospholipase with a typical α/βhydrolase domain and first known deacylated extracellular protein enzyme [35].Emerging evidence have shown that Notum is overexpressed in some primary cancers and served as the biomarker for prognostic. This evidence concerns the gene NOTUM and cancer.